Severe neuromyelitis optica spectrum disorder induced by pucotenlimab: a case report and literature review. [PDF]
Zhang Z, Liao L, Zhou H, Xiang W, Li J.
europepmc +1 more source
Financial Toxicity in Neuromyelitis Optica Spectrum Disorder: An ABC-X Mixed-Methods Study. [PDF]
Wang B +6 more
europepmc +1 more source
Seronegative Neuromyelitis Optica Spectrum Disorder in a Six-Year-Old Patient: A Case Report. [PDF]
Pinacho-Velázquez JL +4 more
europepmc +1 more source
Neuromyelitis Optica-Associated Acute Intermediate Uveitis. [PDF]
Balakrishnan P, Luckett JP, Vaphiades M.
europepmc +1 more source
Cellular therapy in neuromyelitis optica spectrum disorder. [PDF]
Zhong K, Tang Y.
europepmc +1 more source
Glymphatic dysfunction in neuromyelitis optica spectrum disorder. [PDF]
Zhang Y +8 more
europepmc +1 more source
Statement of Retraction: The role of autophagy-related proteins in the pathogenesis of neuromyelitis optica spectrum disorders. [PDF]
europepmc +1 more source
Insufficient mycophenolate mofetil maintenance dosage increases the relapse risk in neuromyelitis optica spectrum disorders. [PDF]
Zhou X +8 more
europepmc +1 more source
Persistent Pathological Yawning due to Neuromyelitis Optica Spectrum Disorder. [PDF]
Saroja AO, Naik KR.
europepmc +1 more source
Longitudinal Spinal Cord Atrophy in Patients With Neuromyelitis Optica Spectrum Disorder and Its Association With Rituximab Treatment. [PDF]
Yao Y +16 more
europepmc +1 more source

